217 related articles for article (PubMed ID: 37938576)
1. Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering.
Lee D; Dunn ZS; Guo W; Rosenthal CJ; Penn NE; Yu Y; Zhou K; Li Z; Ma F; Li M; Song TC; Cen X; Li YR; Zhou JJ; Pellegrini M; Wang P; Yang L
Nat Commun; 2023 Nov; 14(1):6942. PubMed ID: 37938576
[TBL] [Abstract][Full Text] [Related]
2. The potential role of CD16+ Vγ2Vδ2 T cell-mediated antibody-dependent cell-mediated cytotoxicity in control of HIV type 1 disease.
He X; Liang H; Hong K; Li H; Peng H; Zhao Y; Jia M; Ruan Y; Shao Y
AIDS Res Hum Retroviruses; 2013 Dec; 29(12):1562-70. PubMed ID: 23957587
[TBL] [Abstract][Full Text] [Related]
3. Dendritic Cells Are Critical for the Activation and Expansion of Vδ2
Wang X; Liu J; Gao H; Mo XD; Han T; Xu LP; Zhang XH; Huang XJ
Front Immunol; 2018; 9():2528. PubMed ID: 30443256
[TBL] [Abstract][Full Text] [Related]
4. Arming Vδ2 T cells with chimeric antigen receptors to combat cancer.
Thomas P; Paris P; Pecqueur C
Clin Cancer Res; 2024 May; ():. PubMed ID: 38747974
[TBL] [Abstract][Full Text] [Related]
5. Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosis.
Mo F; Tsai CT; Zheng R; Cheng C; Heslop HE; Brenner MK; Mamonkin M; Watanabe N
Cytotherapy; 2024 Mar; ():. PubMed ID: 38506769
[TBL] [Abstract][Full Text] [Related]
6. Opsonized antigen activates Vδ2+ T cells via CD16/FCγRIIIa in individuals with chronic malaria exposure.
Farrington LA; Callaway PC; Vance HM; Baskevitch K; Lutz E; Warrier L; McIntyre TI; Budker R; Jagannathan P; Nankya F; Musinguzi K; Nalubega M; Sikyomu E; Naluwu K; Arinaitwe E; Dorsey G; Kamya MR; Feeney ME
PLoS Pathog; 2020 Oct; 16(10):e1008997. PubMed ID: 33085728
[TBL] [Abstract][Full Text] [Related]
7. Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity.
Poonia B; Pauza CD
Cytotherapy; 2012 Feb; 14(2):173-81. PubMed ID: 22029653
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy accelerates immune-senescence and functional impairments of Vδ2
Bruni E; Cazzetta V; Donadon M; Cimino M; Torzilli G; Spata G; Leonardi G; Dieli F; Mikulak J; Mavilio D
J Immunother Cancer; 2019 Dec; 7(1):347. PubMed ID: 31829255
[TBL] [Abstract][Full Text] [Related]
9. Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.
Varesano S; Zocchi MR; Poggi A
Front Immunol; 2018; 9():998. PubMed ID: 29867975
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells.
Fisher JP; Yan M; Heuijerjans J; Carter L; Abolhassani A; Frosch J; Wallace R; Flutter B; Capsomidis A; Hubank M; Klein N; Callard R; Gustafsson K; Anderson J
Clin Cancer Res; 2014 Nov; 20(22):5720-32. PubMed ID: 24893631
[TBL] [Abstract][Full Text] [Related]
11. Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation.
Couzi L; Pitard V; Moreau JF; Merville P; Déchanet-Merville J
Front Immunol; 2015; 6():3. PubMed ID: 25653652
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2
Liu J; Gao H; Xu LP; Mo XD; Liu R; Liang S; Wu N; Wang M; Wang Z; Chang YJ; Wang Y; Zhang XH; Huang XJ
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221014
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals.
Ryan PL; Sumaria N; Holland CJ; Bradford CM; Izotova N; Grandjean CL; Jawad AS; Bergmeier LA; Pennington DJ
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14378-14383. PubMed ID: 27911793
[TBL] [Abstract][Full Text] [Related]
14. [Allogeneic CAR-NK cells: A promising alternative to autologous CAR-T cells - State of the art, sources of NK cells, limits and perspectives].
Nguyen S; Lacan C; Roos-Weil D
Bull Cancer; 2021 Oct; 108(10S):S81-S91. PubMed ID: 34920811
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid enhances pamidronate-sensitized cytotoxicity of Vδ2
Gao H; Liu R; Wu N; Mo XD; Han W; Huang X; Huang XJ; Liu J
Int Immunopharmacol; 2020 Nov; 88():106890. PubMed ID: 32818705
[TBL] [Abstract][Full Text] [Related]
16. High CD26 and Low CD94 Expression Identifies an IL-23 Responsive Vδ2
Wragg KM; Tan HX; Kristensen AB; Nguyen-Robertson CV; Kelleher AD; Parsons MS; Wheatley AK; Berzins SP; Pellicci DG; Kent SJ; Juno JA
Cell Rep; 2020 Jun; 31(11):107773. PubMed ID: 32553157
[TBL] [Abstract][Full Text] [Related]
17. Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells.
Fisher JP; Flutter B; Wesemann F; Frosch J; Rossig C; Gustafsson K; Anderson J
Oncoimmunology; 2016; 5(1):e1025194. PubMed ID: 26942051
[TBL] [Abstract][Full Text] [Related]
18. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production.
Yin W; Tong S; Zhang Q; Shao J; Liu Q; Peng H; Hu H; Peng M; Hu P; Ren H; Tian Z; Zhang D
Sci Rep; 2016 May; 6():26296. PubMed ID: 27192960
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20. A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell-Mediated Immune Response against EGFR-Expressing Tumors.
King LA; Toffoli EC; Veth M; Iglesias-Guimarais V; Slot MC; Amsen D; van de Ven R; Derks S; Fransen MF; Tuynman JB; Riedl T; Roovers RC; Adang AEP; Ruben JM; Parren PWHI; de Gruijl TD; van der Vliet HJ
Cancer Immunol Res; 2023 Sep; 11(9):1237-1252. PubMed ID: 37368791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
